E2F2 and breast carcinoma: Aliccia Bollig-Fischer found that E2F2 aberrant expression impacts the progression and metastasis of breast cancer cells, E2F2 expression regulated by human epidermal growth factor receptor 2 (HER2) oncogene could impact the cell-matrix adhesion function, with potential consequences for metastatic colonization (19).